Wide variation seen in gluten-free food prescribing

Wide variation seen in gluten-free food prescribing

April 20 2018 Wide variation in gluten-free food (GFF) prescribing does not appear to be driven...

‘Caution in use’ alert issued for Inhixa solution for injection

‘Caution in use’ alert issued for Inhixa solution for injection

April 20 2018 A Class 4 medicines defect alert has been issued relating to Inhixa (enoxaparin...

Views sought on improving health services for people with sensory loss

Views sought on improving health services for people with sensory loss

April 20 2018 Primary care professionals are being asked for views on how to help improve...

Minister: GPs are not precluded from prescribing OTC medicines, but should follow guidance

Minister: GPs are not precluded from prescribing OTC medicines, but should follow guidance

April 20 2018 Doctors have not been prevented from prescribing over-the counter medicines, but...

Epipen manufacturing delays causing stock shortage

Epipen manufacturing delays causing stock shortage

April 17 2018 A manufacturing delay is causing problems around availability of Epipen (Senior)...

  • Wide variation seen in gluten-free food prescribing

    Wide variation seen in gluten-free food prescribing

    Friday, 20 April 2018 16:48
  • ‘Caution in use’ alert issued for Inhixa solution for injection

    ‘Caution in use’ alert issued for Inhixa solution for injection

    Friday, 20 April 2018 16:43
  • Views sought on improving health services for people with sensory loss

    Views sought on improving health services for people with sensory loss

    Friday, 20 April 2018 16:39
  • Minister: GPs are not precluded from prescribing OTC medicines, but should follow guidance

    Minister: GPs are not precluded from prescribing OTC medicines, but should follow guidance

    Friday, 20 April 2018 16:31
  • Epipen manufacturing delays causing stock shortage

    Epipen manufacturing delays causing stock shortage

    Tuesday, 17 April 2018 08:53

a men women toilet signNovember 28 2017

Public Health England is warning that over two fifths of eligible adults are not using the postal screening service for bowel cancer.

Despite 2.6 million people aged over 60 submitting samples, 59% of those eligible and a 3% annual increase on uptake in 2016-17, “this is still significantly lower compared to other cancer screening programmes – breast screening (76%) and cervical screening (72%),” said PHE.

Men in particular seem embarrassed about providing a stool sample, so PHE is urging “wives, partners and daughters to encourage the older men in the family – as well as the women – to overcome any embarrassment and ensure they send in a sample to be tested.”

The bowel cancer screening test is sent to all men and women aged between 60 and 74. The one-off bowel scope screening test is also offered to men and women at the age of 55. Over 3,000 bowel cancers were diagnosed through screening last year, and were detected at an early stage in over 90% of these cases.

Professor Anne Mackie, PHE’s director of screening, said: “It’s of great concern that four out of every ten over-60 year olds are not taking up the offer of getting tested for bowel cancer.

“Bowel cancer causes 13,000 deaths every year, which is why screening is so important. Embarrassment over giving a stool sample may be causing thousands of preventable deaths. But with a new home test kit next year making it much easier to get screened, we are hoping to see numbers increase.”

PHE is encouraging GP to endorse screening invitation letters.

Links:
PHE announcement         
PHE/NHS. ‘Screening Programmes in England 1 April 2016 to 31 March 2017’                  

Professional News

April 20 2018 Wide variation in gluten-free food (GFF) prescribing does not appear to be driven by obvious medical factors, a study has suggested. 
April 20 2018 Wide variation in gluten-free food (GFF) prescribing does not appear to be driven by obvious medical factors, a study has suggested.  GFF prescribing is less likely to occur in areas...